Stanford University
Showing 22,941-22,960 of 36,322 Results
-
Adam Nielander
Staff Scientist, SLAC National Accelerator Laboratory
BioMy research focuses in the areas electrocatalysis, electrolysis, and solar-driven chemical fuel production. We develop catalysts, instrumentation, methodologies, and device engineering/designs for improved production of chemical fuels (e.g., H2, NH3, ethanol) from abundant feedstocks (e.g., H2O, N2, CO2). This work includes in situ and operando studies of catalyst/ionomer interfaces under operating conditions and is underpinned by complementary driving aims to develop next-generation electrochemical technologies and to elucidate the fundamental principles that dictate the performance of sustainably-driven electrochemical processes.
-
Erik Nielsen
Marketing Specialist, Office of Technology Licensing (OTL)
Marketing Specialist, Stanford Office of Technology LicensingBioErik Nielsen (he/him) is a Marketing Specialist on the Business Development and Marketing Team (BDM) at Stanford's Office of Technology Licensing (OTL). He updates and maintains marketing contact and company data, manages preliminary technical marketing tasks, including liaising with inventors, manages the email push campaigns and Techfinder website marketing of Stanford technologies (generally of the Life Sciences), and helps track marketing outreach response. He also assists with special projects as needed, including website content layout, updates, and maintenance. He's worked for Stanford's OTL since early 2018.
Education:
B.A. Psychology, UC Davis -
Koen Nieman
Professor of Medicine (Cardiovascular Medicine) and of Radiology (CV Imaging)
Current Research and Scholarly InterestsDr Nieman investigates advanced cardiac imaging techniques. Current projects focus on the development of functional CT application for hemodynamic interpretation of coronary artery disease, and the clinical validation of cardiac CT in the management of patients with ischemic heart disease.
-
Aina Niemetz
Senior Research Engineer
Biohttps://cs.stanford.edu/people/niemetz
-
Susan Ryan Niermann
Spring CSP Instructor
BioSusan Ryan is a strategic leader, speaker, and creator of the 10% Project—a career and personal growth framework rooted in the belief that big change starts small. With a background in strategy, marketing, and leadership development, Sue has spent her career helping people and ideas grow side by side.
She’s shared her work with audiences ranging from startups to Fortune 50 companies—and inspired individuals across the spectrum: students finding their way, job seekers in transition, professionals dreaming bigger, and retirees rediscovering purpose. Her talks blend clarity, humor, and practical tools that help people take meaningful action without needing to overhaul their entire lives.
The 10% Project started as a single chart in a student presentation. It’s since grown into a full book, a toolkit of worksheets, and a vision for helping individuals move from idea to impact—without burning out.
Sue believes in building careers with purpose, mentoring with heart, and dreaming big (even on a small scale). Her message resonates across roles, ages, and industries—because everyone has a 10% Project waiting to be explored. -
Kenneth Nieser
Postdoctoral Scholar, General Surgery
BioKen Nieser is a postdoctoral research fellow through the Big Data-Scientist Training Enhancement Program (BD-STEP) at the Palo Alto VA and in the Department of Surgery, Stanford School of Medicine. Ken received a BA in Physics and Mathematics from Swarthmore College and a PhD in Epidemiology with a minor in Statistics from the University of Wisconsin-Madison. During his PhD, Ken developed and applied statistical methods for improving algorithmic fairness of data analyses used to inform screening and treatment of mental illnesses. These projects included development of an approach for detecting sample subsets with differential psychological symptom patterns and a sample representation reweighting method for improving the precision of subgroup-specific treatment effect estimation.
Ken’s current research interests are in health care inequities, quality measurement, and algorithmic fairness. During his fellowship, Ken will be working on investigating the statistical reliability of quality measures and decomposing health care disparities to provide practical information for resolving inequities, with applications in mental health care and surgical care. -
Andrea Nightingale
Professor of Classics, Emerita
Current Research and Scholarly InterestsI am completing a book entitled "Eros and Epiphany: Plato on the Soul's Ascent to Divine Beings"
-
Kopal Nihar
Postdoctoral Scholar, Civil and Environmental Engineering
BioI am a postdoctoral scholar working with Dr. Catherine Gorle, Dr. Sarah Billington and Dr. Rishee Jain. I also did a PhD from Stanford advised by Dr Rishee Jain at Urban Informatics Lab. My research interest lies in understanding data-driven human-building interactions and impact of indoor air quality on occupant behaviour, especially for the purpose of natural cooling.
-
Kouta Niizuma
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.
During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.
Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology.
